Reneo Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q1 2025 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q2 2025 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q3 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
Reneo Pharmaceuticals, Inc. Earnings Date And Information
Reneo Pharmaceuticals, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.17 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Reneo Pharmaceuticals, Inc. has generated $-25 earnings per share over the last year ($-25.23 diluted earnings per share) and currently has a price-to-earnings ratio of -10.76. Reneo Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Reneo Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.17 | -$0.16 | 0.01 | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.37 | -$0.25 | 0.12 | $0 | |
| 04/26/2024 | Q4 2023 | -$0.70 | $734,000 | |||
| 11/13/2023 | Q3 2023 | -$0.60 | -$0.57 | 0.03 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.55 | -$0.65 | -0.1 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.63 | -$0.56 | 0.07 | $0 | |
| 03/27/2023 | Q4 2022 | -$0.62 | -$0.52 | 0.1 | $0 | |
| 11/08/2022 | Q3 2022 | -$0.58 | -$0.50 | 0.08 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.60 | -$0.50 | 0.1 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.54 | -$0.53 | 0.01 | $0 | |
| 03/23/2022 | Q4 2021 | -$0.59 | -$0.43 | 0.16 | $0 | |
| 11/12/2021 | Q3 2021 | -$0.52 | $0 | |||
| 08/11/2021 | Q2 2021 | -$0.37 | -$0.43 | -0.06 | $0 | |
| 05/20/2021 | Q1 2021 | -$0.38 | -$0.30 | 0.08 | $0 | |
| 12/31/2020 | Q4 2020 | -$0.26 | $0 | |||
| 09/30/2020 | Q3 2020 | -$0.65 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.47 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.57 | $0 |
Reneo Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Reneo Pharmaceuticals, Inc.'s earnings date?
Reneo Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
Did Reneo Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Reneo Pharmaceuticals, Inc. (:RPHM) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.17 by $0.01.
-
How can I listen to Reneo Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Reneo Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Reneo Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Reneo Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Reneo Pharmaceuticals, Inc. generate each year?
Reneo Pharmaceuticals, Inc. (:RPHM) has a recorded net income of $0. Reneo Pharmaceuticals, Inc. has generated $-25.23 earnings per share over the last four quarters.
-
What is Reneo Pharmaceuticals, Inc.'s price-to-earnings ratio?
Reneo Pharmaceuticals, Inc. (:RPHM) has a price-to-earnings ratio of -10.76 and price/earnings-to-growth ratio is -0.48.
